Multi-Cancer Detection Observational Cohort Study
Mayo Clinic
Summary
This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.
Eligibility
- Age range
- 21+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Has Mayo Clinic medical record number * Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider * Able to provide informed consent * ≥ 21 years old * Ability to provide blood sample Exclusion Criteria: * Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. Federal Medical Prison) * Known pregnancy (self-reported) * Currently undergoing active cancer treatment other than adjuvant hormone therapy * Invasive cancer diagnosis within the last 3 years
Interventions
- ProcedureBlood Sample
Up to 60 mL (about 4-5 Tbsp) of blood may be collected for an initial blood draw and up to 30 mL (about 2-3 Tbsp) may be collected for a second blood draw, 25-45 days after first blood draw. The research blood will be collected at the time of a clinical blood draw, if possible.
- OtherSurveys
Participants will complete surveys related to attitudes and beliefs around Multi-Cancer Detection testing.
Locations (3)
- Mayo Clinic in ArizonaScottsdale, Arizona
- Mayo Clinic in FloridaJacksonville, Florida
- Mayo Clinic in RochesterRochester, Minnesota